Trust is the product.

I work both sides of the healthcare AI table — helping the companies that build it get through procurement, and helping the organizations that buy it make decisions they won't regret.

For Healthcare Organizations

Buyer's guides, cohort workshops, AI strategy

For Healthtech Teams

Enterprise readiness, technical diligence, board advisory, investor diligence

The two sides

Building healthtech?

I help regulated health AI companies choose the right wedge, then build the product, evidence, and governance that gets through enterprise procurement and scales. I also provide technical diligence for investors evaluating digital health and AI targets.

Founders and executives. VC and PE investors. Board members.

How I help healthtech teams

Running a healthcare organization?

I help RHCs, CAHs, FQHCs, and health systems figure out where AI actually fits in their operations — and build the strategy, the evaluation framework, and the funding narrative to get it right.

Free buyer's guides. Cohort workshops. AI strategy and roadmaps.

How I help healthcare organizations
$81M

in revenue unlocked for a top-5 biopharma

30+

regulated products shipped

18+

years in the seat, not across the table

Companies where I've built, shipped, or sold

NHS
Labcorp
CooperVision
American Red Cross
AliveCor
Gilead
Moderna
Johnson & Johnson
Y Combinator
Boston Scientific

What I actually do

For healthtech companies and investors, I evaluate whether products are built to scale or just built to sell. Technical diligence for M&A and investment. Enterprise readiness for founders stuck in pilot purgatory. Regulatory strategy across FDA, HIPAA, and EU AI Act. Board advisory for regulated companies navigating growth.

For healthcare organizations, I wrote the buyer's guides that RHCs, CAHs, and FQHCs are using to evaluate AI tools — grounded in UDS, 340B, cost-based reimbursement, PPS economics, and the operational realities vendors overlook. For organizations that need strategy before they can evaluate, I run cohort workshops that produce a prioritized plan and a funding narrative in a single day.

The connection between the two: every healthtech company I advise becomes better at selling to the organizations I help. Every healthcare organization I work with becomes a more sophisticated buyer that rewards the vendors who've done the work. Both sides benefit from the other side getting better.

Featured

The Buyer's Guides

Free evaluation frameworks for RHCs, CAHs, and FQHCs. What to buy, what to ask, when to walk away.

View the guides

Vendor Readiness Diagnostic

How ready is your healthtech product for safety-net procurement? Eight dimensions, scored.

Read the diagnostic

Why Enterprise Deals Stall

The structural reasons healthtech pilots don't convert — and what to do about it.

Read on Substack

From people I've worked with

Chuck Harris

Chuck Harris

ex-CEO at endpoint Clinical

"Arvita crushes challenging problems and creates order where there is uncertainty. As CEO, I hired her and she became an integral member of the leadership team. Arvita impressed me with her ability to juggle multiple projects, coax the best out of her team, and break down silos to get things done. I hired her again to join me on the founding team at Korio."
Andrew Paterson

Andrew Paterson

CTO at Clip Health, YC-backed startup

"Arvita asks poignant questions that would push others to rethink assumptions. She has an impressive set of leadership skills, which enable her to develop and promote a positive, high-performance work culture."
Michael Morgan-Curran

Michael Morgan-Curran

CEO at Asclepius MedTech, VC-backed startup

"Arvita was able to help prioritize which go-to-market strategies would be successful. She is committed and passionate about delivering her projects on time and done well!"
Arvita Tripati

About Arvita

19 years building regulated products that had to survive FDA scrutiny, enterprise procurement, and post-acquisition integration. Product and compliance executive at AliveCor, Vineti, and endpoint Clinical (LabCorp). Built engineering, product, and compliance functions from scratch. Products serve Moderna, Gilead, NHS, and Bristol-Myers Squibb. Carnegie Mellon Chief Data and AI Officer program.

Now I work both sides: helping investors evaluate whether targets are enterprise-ready, helping founders build companies that pass that test, and helping the healthcare organizations on the other side of the table make better technology decisions.

Currently: Diligence team, Scaling Care Fund. Pop-up board member, IOVC. Illumyn Board Fellow. Board Member, Red Dot Ranch.

Not sure where to start?

Whether you're building healthtech, investing in it, or trying to figure out whether to buy it — I'll tell you honestly which of my resources or services fits your situation, if any.

Book a Discovery Call